Рет қаралды 23
Day 6: #30Yearsin30Days
For 30 years, SECTION27 has championed #AccesstoMeds.
Now they are involved in what could be a groundbreaking case for affordable access to medicines in South Africa.
The Treatment Action Campaign (TAC) and Doctors Without Borders (MSF) Southern Africa, filed papers in the Pretoria High Court to intervene as amici curiae (friends of the court) in a compulsory license application for access to a lifesaving drug to treat #cysticfibrosis, called Trikafta.
Cystic fibrosis patient, Cheri Nel brought a case against an American pharmaceutical company, Vertex Pharmaceuticals Inc, that patented Trikafta, a life saving drug exorbitantly priced at R5 million.
#30yearsofsocialjustice
WATCH | Former SECTION27 Legal Researcher, Baone Twala explain what a compulsory license is.